Roxithromycin. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Roxithromycin. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Notes Undergr. 1995 Winter;(no 29):3-4. Unique Identifier : AIDSLINE AIDS/95700302


Abstract: The PWA Health Group now distributes roxithromycin (Ruclid) for cryptosporidiosis. Cryptosporidium parvum is a single-cell parasite that produces chronic watery diarrhea in people with compromised immune systems. Roxithromycin, a macrolide antibiotic, currently is used extensively in Europe and Latin America to treat a number of bacterial infections, including chlamydia, sinusitis, and skin and respiratory problems. At the 1994 International AIDS Conference, reports of two clinical studies showed that roxithromycin might effectively treat cryptosporidiosis. In both studies, patients took 300 mg of Roxy twice a day. In one study, complete clearance was seen in 5 patients, with improvement in 3 patients. Side effects of the drug seem to be minimal. One major concern is the possibility of elevated liver enzymes.
Keywords: AIDS-Related Opportunistic Infections/*DRUG THERAPY Clinical Trials Cryptosporidiosis/*DRUG THERAPY Feces/PARASITOLOGY Human Liver/ENZYMOLOGY Roxithromycin/ADVERSE EFFECTS/*THERAPEUTIC USE NEWSLETTER ARTICLEKWDaids-relatedopportunisticinfections/KWDdrugtherapyclinicaltrialscryptosporidiosis/KWDdrugtherapyfeces/parasitologyhumanliver/enzymologyroxithromycin/adverseeffects/KWDtherapeuticusenewsletterarticle
950930
M9591268

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .